Rogaratinib
Rogaratinib (BAY1163877) is a potent, selective, and orally bioavailable small molecule inhibitor targeting FGFR1, FGFR2, and FGFR3 kinase activity. It is widely used in preclinical research to investigate FGFR-driven pathologies, including in studies of cancer cell proliferation and tumor growth in both cellular and animal models.
Product Specifications
CAS Number
1443530-05-9
Product Name Alternative
BAY1163877, BAY-1163877, BAY 1163877, Inhibitor, FGFR4, FGFR3, FGFR2, FGFR, FGFR1, Fibroblast growth factor receptor, inhibit, Rogaratinib
Field of Research
Cardiovascular Research, Signal Transduction
Purity
99.54% (May vary between batches)
Solubility
DMSO:5.5 mg/mL (11.79 mM)
Smiles
COCc1c (CN2CCNC (=O) C2) n2ncnc (N) c2c1-c1cc2cc (C) cc (OC) c2s1
Molecular Formula
C23H26N6O3S
Molecular Weight
466.56
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
orb1659485 96 Tests
Mouse Pyridoxal phosphate phosphatase ELISA Kit
Sign In for Pricing
View Details 
